2016
DOI: 10.21037/atm.2016.03.28
|View full text |Cite
|
Sign up to set email alerts
|

Importance of tumor infiltrating lymphocytes in non-small cell lung cancer?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 22 publications
1
3
0
Order By: Relevance
“…We found sTIL appears to have a superior prognostic impact when compared with iTIL, which is previously reported in other tumours2122. In this study, we confirmed that sTIL constitutes a robust and independent prognostic marker in ESCC, with increasing sTIL predictive of a significantly lower risk of recurrence or metastasis, and overall mortality.…”
Section: Discussionsupporting
confidence: 88%
“…We found sTIL appears to have a superior prognostic impact when compared with iTIL, which is previously reported in other tumours2122. In this study, we confirmed that sTIL constitutes a robust and independent prognostic marker in ESCC, with increasing sTIL predictive of a significantly lower risk of recurrence or metastasis, and overall mortality.…”
Section: Discussionsupporting
confidence: 88%
“…Most studies on lung cancer regarding tumor infiltrating ICs and PD-1/PD-L1 expression have been performed in NSCLC as a single cohort comprising at least both adenocarcinomas and squamous cell carcinomas. 14,30,[35][36][37][38] Moreover, studies on brain metastasis also included metastases pooled from various sites of origin, 16,17 so the well-known biological and therapeutic differences among the various histological subtypes may have a strong influence on the results. Therefore, in our present work we focused exclusively on brain metastasis cases from lung adenocarcinoma (LUAD) to create a more homogeneous cohort.…”
Section: Importance Of the Studymentioning
confidence: 99%
“…NSCLC histopathology is characterized by a complex interplay of tumor cells, immune cells (lymphocytes, plasma cells, macrophages, and granulocytes), fibroblasts, and pericytes/endothelial cells. Recent evidence suggests that the interaction of tumor cells with immune cells has a high association with likelihood of disease progression and influences tumor development, invasion, metastasis, and patient outcome (1,2). Several independent studies (2, 4-6) meanwhile have also shown an association between patient survival and treatment response with an increased density of tumor-infiltrating lymphocytes (TIL) in diverse solid tumor types.…”
Section: Introductionmentioning
confidence: 99%